Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2008
05/15/2008WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008WO2008055950A1 Novel inhibitors of glutaminyl cyclase
05/15/2008WO2008037789A8 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
05/15/2008WO2008036843A3 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
05/15/2008WO2008008660B1 Cyclopentane derivatives as antiglaucoma agents
05/15/2008WO2008008310A3 Tyrosine kinase inhibitors
05/15/2008WO2007138112A3 Compounds that interact with ion channels, in particular with ion channels from the kv family
05/15/2008US20080114052 Cyclic derivatives as modulators of chemokine receptor activity
05/15/2008US20080114036 Novel Compounds, Their Preparations And Use
05/15/2008US20080114030 Diarymethyl and related compounds
05/15/2008US20080114013 Spiroindolinone derivatives
05/15/2008US20080113993 Barbituric acid analogs as therapeutic agents
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008US20080113967 Enzyme modulators and treatments
05/15/2008US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use
05/15/2008DE102006053637A1 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted with fluorine 1,4-benzothiepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
05/15/2008DE102006053635A1 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
05/15/2008CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators
05/15/2008CA2668840A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
05/15/2008CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008CA2667644A1 Tricyclic compounds as matrix metalloproteinase inhibitors
05/14/2008EP1921066A1 Pyridylphenol compound and use thereof
05/14/2008EP1919907A2 Heterocyclic compound
05/14/2008EP1919876A1 Method for producing substituted pyrazoles
05/14/2008EP1919873A1 Fredericamycin derivatives
05/14/2008EP1919865A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
05/14/2008EP1664013B1 Calcilytic compounds
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/14/2008EP1480683B1 Near infrared fluorescent contrast agent and method for fluorescence imaging
05/14/2008CN101180298A New antibiotic derivatives
05/14/2008CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
05/14/2008CN101180291A Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists
05/14/2008CN101180290A Hydogrenated benzo[c] thiophene derivatives as immunomodulators
05/14/2008CN101180050A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
05/14/2008CN100388201C Program code size partitioning system and method for multiple memory multi-processing systems
05/14/2008CN100387127C Fungicides
05/13/2008US7371872 (1R,4S,5S,6S)-4-(2'S-4'-methylthio-2'-aminobutanonyl)amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid; nervous system, psychological, and psychiatric disorders
05/13/2008US7371869 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders
05/13/2008US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields
05/13/2008US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties
05/13/2008US7371764 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide
05/13/2008US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/13/2008US7371755 Antiviral agents
05/13/2008US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
05/08/2008WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
05/08/2008WO2008053812A1 Cyanopyridine derivative and medicinal use thereof
05/08/2008WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
05/08/2008WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents
05/08/2008US20080108834 Small molecular thiophene compound having divalent linkage
05/08/2008US20080108833 Small molecular thiophene compound
05/08/2008US20080108832 Aromatic amine derivatives and organic electroluminescent device using same
05/08/2008US20080108808 Dipeptidyl peptidase inhibitors
05/08/2008US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
05/08/2008US20080108682 reaction of R-(-)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol with 7-chloro benzothiaphene derivatives to give highly purified R-(-)-sertaconazole mononitrate hemiacetonate or R-(-)-sertaconazole mononitrate; infections caused by fungi and yeasts; higher yield; low cost
05/08/2008US20080108601 anticancer agents; catalytic hydrogenation
05/08/2008US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators
05/08/2008US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same
05/08/2008CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
05/07/2008EP1918275A1 Production method of diphenylalanine - NI(II) complex
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008EP1917323A1 Novel materials for organic electroluminescent devices
05/07/2008EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists
05/07/2008EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors
05/07/2008EP1917251A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
05/07/2008EP1917248A1 1-acyldihydropyrazol derivatives
05/07/2008EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments
05/07/2008EP1917246A1 Benzoquinazoline derivatives and their use in treating bone disorders
05/07/2008EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
05/07/2008EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
05/07/2008EP1603874B1 G-lactam derivatives as prostaglandin agonists
05/07/2008EP1592680B1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
05/07/2008EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
05/07/2008EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
05/07/2008EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
05/07/2008EP1299381B1 Substituted quinazoline derivatives and their use as inhibitors
05/07/2008CN101175750A Fungicide 2-pyridyl-methylene-carboxamide derivatives
05/07/2008CN100386318C Tetrahydroquinoline derivatives and their use as FSH receptor modulators
05/06/2008US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
05/06/2008US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
05/06/2008US7368539 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
05/06/2008US7368465 Metalloproteinase inhibitors
05/06/2008US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/06/2008US7368450 Sodium channel blockers
05/06/2008US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress
05/06/2008CA2430601C Piperazine derivatives
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008050732A1 Iminopyridine derivative and use thereof
05/02/2008WO2008049919A2 Rho kinase inhibitors
05/02/2008WO2008049875A1 Novel substituted piperidyl-propane-thiols
05/02/2008WO2008049585A1 Pyridazine derivatives
05/02/2008WO2008019971A3 Arylpiperazine derivatives and uses thereof
05/02/2008WO2008019030A8 Modified azole compounds as antiinfective agents
05/02/2008CA2667548A1 Substituted piperidyl-propane-thiols
05/02/2008CA2667235A1 Pyridazine derivatives
05/01/2008US20080103316 Reduction of 4-aryl-4-ketobutanoic acid derivatives utilizing ruthenium containing catalysts
05/01/2008US20080103230 Monomers for polyepisulfides, polythiourethanes, or acrylic esters with internal thio groups; optical lens protective coatings with a high refractive index; reacting a bis-ethylenetrithiocarbonate sulfide or bis-ethylenetrithiocarbonate with an oxirane or thiirane and tetrafluoroboric acid catalyst
05/01/2008US20080103180 CCR9 inhibitors and methods of use thereof